These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2107184)

  • 1. Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: phospholipase activation and deacylation of specific-membrane phospholipids.
    Knauer MF; Longmuir KJ; Yamamoto RS; Fitzgerald TP; Granger GA
    J Cell Physiol; 1990 Mar; 142(3):469-79. PubMed ID: 2107184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipases are activated during cell destruction by human alpha-lymphotoxin in vitro.
    Fitzgerald MT; Longmuir KJ; Granger GA
    Lymphokine Res; 1987; 6(4):319-24. PubMed ID: 3501507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
    J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor.
    Neale ML; Fiera RA; Matthews N
    Immunology; 1988 May; 64(1):81-5. PubMed ID: 3133309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of interleukin-1 and tumor necrosis factor-alpha induced granulocyte-macrophage colony-stimulating factor gene expression: potential involvement of arachidonic acid metabolism.
    Rizzo MT; Boswell HS
    Exp Hematol; 1994 Jan; 22(1):87-94. PubMed ID: 8282065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer.
    Cappuccini F; Yamamoto RS; DiSaia PJ; Grosen EA; Gatanaga M; Lucci JA; Ininns EK; Gatanaga T; Granger GA
    Lymphokine Cytokine Res; 1991 Jun; 10(3):225-9. PubMed ID: 1653048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
    J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of phospholipase activation in cell killing.
    Ciba Found Symp; 1987; 131():83-7. PubMed ID: 3502461
    [No Abstract]   [Full Text] [Related]  

  • 11. Fragmentation of cellular DNA is a nonspecific indicator of responsiveness to tumor necrosis factor.
    Rubin BY; Anderson SL; Lunn RM; Hellermann GR; Smith LJ
    J Biol Response Mod; 1989 Oct; 8(5):553-9. PubMed ID: 2507749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor.
    Schmid DS; Hornung R; McGrath KM; Paul N; Ruddle NH
    Lymphokine Res; 1987; 6(3):195-202. PubMed ID: 3498099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion.
    Kubota S; Takeda K; Yamada T; Nomura Y; Takeda M; Iwamoto S; Seyama Y
    Cancer Lett; 1996 Jan; 98(2):233-40. PubMed ID: 8556714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
    Hochman PS; Majeau GR; Mackay F; Browning JL
    J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells.
    Fletcher WH; Shiu WW; Ishida TA; Haviland DL; Ware CF
    J Immunol; 1987 Aug; 139(3):956-62. PubMed ID: 3110292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
    Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
    Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se.
    Suffys P; Beyaert R; De Valck D; Vanhaesebroeck B; Van Roy F; Fiers W
    Eur J Biochem; 1991 Jan; 195(2):465-75. PubMed ID: 1847684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells.
    Iwamoto S; Shibuya I; Takeda K; Takeda M
    Biochem Biophys Res Commun; 1994 Feb; 199(1):70-7. PubMed ID: 8123048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.